117 related articles for article (PubMed ID: 19224757)
1. Herpes zoster in the age of focused immunosuppressive therapy.
Whitley RJ; Gnann JW
JAMA; 2009 Feb; 301(7):774-5. PubMed ID: 19224757
[No Abstract] [Full Text] [Related]
2. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
3. Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?
Bongartz T; Orenstein R
Nat Rev Rheumatol; 2009 Jul; 5(7):361-3. PubMed ID: 19568250
[No Abstract] [Full Text] [Related]
4. Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry.
Serac G; Tubach F; Mariette X; Salmon-Céron D; Ravaud P; Lioté F; Laharie D; Ziza JM; Marguerie L; Bonnet C; Falgarone G; Nicolas N; Lortholary O; Chosidow O
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):726-9. PubMed ID: 22113472
[No Abstract] [Full Text] [Related]
5. Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy.
Winthrop KL; Furst DE
Ann Rheum Dis; 2010 Oct; 69(10):1735-7. PubMed ID: 20858622
[No Abstract] [Full Text] [Related]
6. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
[TBL] [Abstract][Full Text] [Related]
7. Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody.
Kubandova Z; Mathieu S; Pourtier C; Soubrier M
Joint Bone Spine; 2010 Dec; 77(6):623-4. PubMed ID: 20851657
[No Abstract] [Full Text] [Related]
8. Protracted herpes zoster and severe postherpetic neuralgia after inadvertant infliximab administration.
Failla V; Castronovo C; Meex C; Nikkels AF
Eur J Dermatol; 2011; 21(5):782-3. PubMed ID: 21700542
[No Abstract] [Full Text] [Related]
9. Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor-α.
Javed S; Kamili QU; Mendoza N; Tyring SK
J Med Virol; 2011 Nov; 83(11):2051-5. PubMed ID: 21915882
[TBL] [Abstract][Full Text] [Related]
10. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
11. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Hochman D; Wolff B
JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
[No Abstract] [Full Text] [Related]
12. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Callegari PE; Schaible TF; Boscia JA
JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
[No Abstract] [Full Text] [Related]
13. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Costenbader KH; Glass R; Cui J; Shadick N
JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
[No Abstract] [Full Text] [Related]
14. [Serious lung disease in RA and TNF-blockade--is there a connection?].
Turesson C; Jacobsson L; Saxne T; Geborek P
Lakartidningen; 2006 Feb 1-7; 103(5):308; author reply 308-9. PubMed ID: 16512575
[No Abstract] [Full Text] [Related]
15. Systemic listeriosis with adalimumab therapy.
Murphy G; Schmidt-Martin D; Hynes BG; Harney S
J Clin Rheumatol; 2009 Oct; 15(7):369-70. PubMed ID: 20009978
[No Abstract] [Full Text] [Related]
16. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
[No Abstract] [Full Text] [Related]
17. Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?
Bendtzen K
Arthritis Rheum; 2011 Apr; 63(4):867-70. PubMed ID: 21452309
[No Abstract] [Full Text] [Related]
18. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
19. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Okada SK; Siegel JN
JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Gabriel SE
Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805
[No Abstract] [Full Text] [Related]
[Next] [New Search]